Recent Publications

GB Taylor, JE McNeal, RJ Cohen. Intraductal carcinoma of the prostate metastatic to the penile urethra: a rare demonstration of two morphologic patterns of tumour growth. Pathology 1998, 30: 218-221


RJ Cohen, WC Chan, SG Edgar, E,Robinson, N Dodd, S Hoscek, IP Mundy. Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma. British Journal of Urology International 1998; 81: 413-418


RJ Cohen, S Stables. Intraprostatic fat. Human Pathology 1998; 29 (4): 424-425


RJ Cohen, JE McNeal, SG Edgar, T Robertson, HJS Dawkins. Characterisation of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma. Human Pathology 1998; 29: 1488-1494


AE Norrish, CU McRae, RJ Cohen, RT Jackson. A population based study of clinical and pathological prognostic characteristics of men with familial and sporadic prostate cancers. British Journal of Urology International 1999; 84 (3): 311-315


RJ Cohen, JC Stanley, HJS Dawkins. Lymphoepithelioma-like carcinoma of the renal pelvis. Pathology 1999; 31: 434-435


RJ Cohen, JE McNeal, T Bailley. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate; significance for cancer progression. The Prostate 2000; 43:11-19


RJ Cohen, JE McNeal, SL Redmond, K Meehan, R Thomas, M Wilce, HJS Dawkins. Luminal contents of benign and malignant prostatic glands: correspondence to altered secretory mechanisms. Human Pathology 2000; 31: 94-100


RJ Cohen , S Weinstein, T Robertson, LN Sellner, HJS Dawkins, JE McNeal. Variant chromophobe renal cell carcinoma; a morphology not recognised after routine fixation. Archives of Pathology & Laboratory Medicine 2000; 124: 904-906


HJS Dawkins, LN Sellner, GR Turbett, CA Thompson, SL Redmond, JE McNeal , RJ Cohen. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN) and invasive prostatic adenocarcinoma using molecular markers of cancer progression. The Prostate 2000; 44: 265-270


RJ Cohen, JW Holland, SL Redmond, JE McNeal, HJS Dawkins. The identification of the glycosaminoglycan keratan sulphate in the prostatic secretory cell. The Prostate 2000; 44: 204-209


RJ Cohen, JE McNeal, M Susman, LN Sellner, BJ Iacopetta, SL Weinstein, HJS Dawkins. Sarcomatoid renal cell carcinoma of papillary origin: a case report and cytogenetic evaluation. Archives of Pathology & Laboratory Medicine 2000; 24: 1830-1832


TJ Walton, JC Stanley, R Davies, RJ Cohen. Renal malignancy in the absence of a mass lesion. Australian & New Zealand Journal of Surgery 2001; 71: 388-390


RJ Cohen, MP Beales, JE McNeal. Prostate secretory granules (PSG) in normal and neoplastic prostate glands; a diagnostic aid to needle biopsy. Human Pathology 2000; 31:1515-1519


JE McNeal, RJ Cohen, JD Brooks. Role of cytological criteria in the histological diagnosis of Gleason grade 1 adenocarcinoma. Human Pathology 2001; 32: 441-446


RJ Cohen, G Fischer, JE McNeal Immunostains after glutaraldehyde-based tissue fixation. Human Pathology 2001; 32 (2): 242-243


RJ Cohen, K Fujiwara, JW Holland, JE McNeal. The identification of polyamines in prostatic epithelial cells and adenocarcinoma; the effects of androgen blockade. The Prostate 2001; 49: 278-284


RJ Cohen, K Garrett, JL Golding, RB Thomas, JE McNeal. Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands. Human Pathology 2002; 33 (9): 905-909


B Shannon, ZS Wisniewski, J Bentel, RJ Cohen. Rhabdoid differentiation of clear-cell and chromophobe renal cell carcinoma. Pathology 2003; 35 (3): 228-230


B Shannon, A Vasudevan, RJ Cohen. Abnormal Leydig cells in cryptorchid testes: a report of two cases. Pathology 2003; 35 (3): 269-270


B Shannon, ZS Wisniewski, J Bentel, RJ Cohen. Adult rhabdoid renal cell carcinoma: divergent differentiation of conventional (clear-cell) carcinoma. Archives of Pathology & Laboratory Medicine 2002; 126: 1506-1510


KL Garrett, JE McNeal, RJ Cohen. Intra-operative lymph node staging of prostate cancer: the case against. Australian & New Zealand Journal of Surgery 2003; 73: 263-266


JP Higgins, R Shinghal, H Gill, JH Reese, M Terris, RJ Cohen, M Fero, JR Pollack, M van de Rijn, JD Brooks. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. American Journal of Pathology 2003; 162 (3): 925-32


N Samnakay, RJ Cohen, J Orford, PA King, RJ Davies. Androgen and oestrogen receptor status of the human appendix testis. Pediatric Surgery International 2003; 19 (7): 520-4


BA Shannon, JE McNeal, RJ Cohen. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour. Pathology 2003; 35 (6): 467-472


BA Shannon, A Murch, RJ Cohen. Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma. Archives of Pathology & Laboratory Medicine 2005; 129: 238-240


RJ Cohen, BA Shannon, JE McNeal, T Shannon, KL Garrett, Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? Journal of Urology 2005; 173 (6): 1969-74


RJ Cohen. Neuroendocrine carcinoma of the prostate gland. Pathology 2005; 37 (4): 326-327


A Vasuvaden, RJ Davies, BA Shannon, RJ Cohen. Incidental renal tumours: the frequency of benign lesions and the role of pre-operative core biopsy. British Journal of Urology International 2006; 97 (5): 946-949


BA Shannon, KL Garrett, RJ Cohen. PCR-based identification of Propionibacterium acnes types isolated from the male urinary tract: evaluation of adolescents, normal adults and males with prostatic pathology. British Journal of Urology International 2006; 98: 388-392


BA Shannon, KL Garrett, RJ Cohen. Links between Propionibacterium acnes and prostate cancer. Future Oncology 2006; 2: 225-232


RJ Cohen, TM Wheeler, H Bonkhoff, MA Rubin. A proposal on the identification histologic reporting and implications of intraductal prostatic carcinoma. Archives of Pathology & Laboratory Medicine 2007; 131: 1103-1109


RJ Cohen, BA Shannon, SL Weinstein. Intraductal carcinoma of the prostate gland with transmucosal spread to the seminal vesicle: a lesion distinct from high-grade prostatic intraepithelial neoplasia. Archives of Pathology & Laboratory Medicine 2007; 131: 1122-1125


RJ Cohen, BA Shannon. Tubulovillous adenoma of the prostatic urethra: a rare and usually indolent lesion distinct from prostatic adenocarcinoma. Pathology 2007; 39 (5): 522-524


BA Shannon, K Garrett, RJ Cohen. Antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. British Journal of Urology International 2008; 101 (4): 429-435


OA Alexeyev, B Marklund, B Shannon, I Golovleva, J Olsson, C Andersson, I Eriksson, R Cohen, F Elgh. Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assay. Journal of Clinical Microbiology 2007; 45 (11): 3721-3728


RJ Cohen, TM Wheeler, H Bonkhoff, MA Rubin. Lesions of ductal morphology – reply. Archives of Pathology & Laboratory Medicine 2008; 132: 320-321


RJ Cohen, BA Shannon, M Phillips, RE Moorin, TM Wheeler, KL Garrett. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. Journal of Urology 2008;179: 1762-1767


S Sundararajan, J Dyer, R Pemberton, RJ Cohen. Asymptomatic giant renal oncocytoma presenting with hypertension. Pathology 2008; 40: 723-724


BA Shannon, RJ Cohen, H deBruto, RJ Davies. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. Journal of Urology 2008; 180: 1257-1261


BA Shannon, RJ Cohen, K Garrett. Influence of 16S rDNA primer sequence mismatches on the spectrum of bacterial genera detected in prostate tissue by universal eubacterial PCR. Prostate 2008; 68: 1487-1491


BA Shannon, RJ Cohen, A Segal, E Baker, A Murch. Clear cell renal cell carcinoma with smooth muscle stroma. Human Pathology 2009; 40 (3): 425-9


SM Ooi, JB Vivian, RJ Cohen. The Use of Ki-67 marker in the pathologic diagnosis of the epithelioid variant of renal angiomyolipoma. International Urology & Nephrology 2009; 41 (3): 559-565


I Leav, J Plescia, HL Goel, J Li, Z Jiang, RJ Cohen, LR Languino, DC Altieri. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localised and metastatic cancer. The American Journal of Pathology 2010; 176: 393-401


BA O’Brien, AL Brown, T Shannon, RJ Cohen. Prostate biopsy in Western Australia 1998- 2004. Prostate Cancer & Prostatic Diseases 2010; 13: 263-269


BA O’Brien, RJ Cohen, TM Wheeler, RE Moorin. A post-radical prostatectomy nomogram incorporating new pathologic parameters and interaction terms for improved prognostication. British Journal of Urology International 2011; 107 (3): 389-395


RJ Cohen, BA O’Brien. Comment: comparative analysis of three risk assessment tools in Australian patients with prostate cancer. British Journal of Urology International Suppl 2011; 2: 56-57


A Brown, RJ Cohen, BA O’Brien. Inverted papilloma of the urinary tract. British Journal of Urology International Suppl 2011; 107 (3): 24-26


RJ Cohen, BA O’Brien, TM Wheeler. Desquamating apoptotic variant of intraductal carcinoma of the prostate. Human Pathology 2011; 42: 892-895


RJ Cohen, BA O’Brien, TM Wheeler. Ductal adenocarcinoma of the prostate. Human Pathology 2011; 42 (4): 606-607


C Wood, BA O’Brien, RJ Cohen. Benign prostatic glands as a tissue component of testicular teratoma; an uncommon histological finding. Pathology 2011; 43 (2): 168-169


BA O’Brien, RJ Cohen, A Ryan, S Sengupta, J Mills. A new pre-operative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools for selecting active surveillance patients. Journal of Urology 2011; 186: 1811-1817


N Kuroda, S Mikami, CC Pan, RJ Cohen, O Hes, M Michal, Y Nagashima, Y Tanaka, K Inoue, T Shuin, GH Lee. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histology & Histopathology 2012; 27 (2): 133-140


S Lee, S Walsh, CG Woods, H Bonkhoff, RJ Cohen. Reliable identification of transition zone prostatic Adenocarcinoma in pre-operative needle core biopsy. Human Pathology 2013 (10): 2331-2337.